Genetic Technologies Ltd (GTG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Genetic Technologies Ltd (GTG) has a cash flow conversion efficiency ratio of 0.067x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-144.47K ≈ $-102.22K USD) by net assets (AU$-2.17 Million ≈ $-1.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Genetic Technologies Ltd stock valuation for the company's overall valuation and market capitalisation.
Genetic Technologies Ltd - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how Genetic Technologies Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Genetic Technologies Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Genetic Technologies Ltd ranked by their cash flow conversion efficiency. Explore how high is Genetic Technologies Ltd's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Gooch & Housego Plc
LSE:GHH
|
0.046x |
|
Strike Resources Ltd
AU:SRK
|
-0.102x |
|
SIXTY SIX CAPITAL INC.
F:5CR0
|
-0.046x |
|
Winshear Gold Corp
V:WINS
|
-0.273x |
|
Entreprendre
PA:ALENR
|
0.003x |
|
McBride plc
LSE:MCB
|
0.155x |
|
Allergy Therapeutics
LSE:AGY
|
-2.755x |
|
C29 Metals Ltd
AU:C29
|
-4.714x |
Annual Cash Flow Conversion Efficiency for Genetic Technologies Ltd (2000–2024)
The table below shows the annual cash flow conversion efficiency of Genetic Technologies Ltd from 2000 to 2024. View Genetic Technologies Ltd stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-06-30 | AU$1.83 Million ≈ $1.30 Million |
AU$-9.68 Million ≈ $-6.85 Million |
-5.288x | -507.08% |
| 2023-06-30 | AU$11.16 Million ≈ $7.90 Million |
AU$-9.72 Million ≈ $-6.88 Million |
-0.871x | -152.89% |
| 2022-06-30 | AU$16.43 Million ≈ $11.63 Million |
AU$-5.66 Million ≈ $-4.00 Million |
-0.344x | -17.80% |
| 2021-06-30 | AU$21.53 Million ≈ $15.24 Million |
AU$-6.30 Million ≈ $-4.45 Million |
-0.292x | +28.38% |
| 2020-06-30 | AU$13.99 Million ≈ $9.90 Million |
AU$-5.71 Million ≈ $-4.04 Million |
-0.408x | +88.09% |
| 2019-06-30 | AU$1.77 Million ≈ $1.25 Million |
AU$-6.07 Million ≈ $-4.30 Million |
-3.429x | -186.63% |
| 2018-06-30 | AU$4.71 Million ≈ $3.33 Million |
AU$-5.64 Million ≈ $-3.99 Million |
-1.196x | -85.73% |
| 2017-06-30 | AU$10.58 Million ≈ $7.49 Million |
AU$-6.81 Million ≈ $-4.82 Million |
-0.644x | +0.95% |
| 2016-06-30 | AU$11.88 Million ≈ $8.41 Million |
AU$-7.73 Million ≈ $-5.47 Million |
-0.650x | -27.20% |
| 2015-06-30 | AU$18.96 Million ≈ $13.41 Million |
AU$-9.69 Million ≈ $-6.86 Million |
-0.511x | +91.50% |
| 2014-06-30 | AU$1.83 Million ≈ $1.29 Million |
AU$-10.99 Million ≈ $-7.77 Million |
-6.012x | -360.56% |
| 2013-06-30 | AU$5.76 Million ≈ $4.07 Million |
AU$-7.52 Million ≈ $-5.32 Million |
-1.305x | -144.99% |
| 2012-06-30 | AU$14.40 Million ≈ $10.19 Million |
AU$-7.67 Million ≈ $-5.43 Million |
-0.533x | -262.57% |
| 2011-06-30 | AU$6.81 Million ≈ $4.82 Million |
AU$2.23 Million ≈ $1.58 Million |
0.328x | +143.55% |
| 2010-06-30 | AU$5.72 Million ≈ $4.05 Million |
AU$-4.30 Million ≈ $-3.04 Million |
-0.753x | -115.70% |
| 2009-06-30 | AU$17.49 Million ≈ $12.37 Million |
AU$-6.10 Million ≈ $-4.32 Million |
-0.349x | -1815.27% |
| 2008-06-30 | AU$20.83 Million ≈ $14.74 Million |
AU$423.68K ≈ $299.78K |
0.020x | -84.38% |
| 2007-06-30 | AU$16.90 Million ≈ $11.96 Million |
AU$2.20 Million ≈ $1.56 Million |
0.130x | +138.82% |
| 2006-06-30 | AU$18.27 Million ≈ $12.92 Million |
AU$-6.13 Million ≈ $-4.33 Million |
-0.335x | -15.98% |
| 2005-06-30 | AU$22.75 Million ≈ $16.10 Million |
AU$-6.58 Million ≈ $-4.65 Million |
-0.289x | -9.13% |
| 2004-06-30 | AU$17.07 Million ≈ $12.08 Million |
AU$-4.52 Million ≈ $-3.20 Million |
-0.265x | -627.25% |
| 2003-06-30 | AU$27.28 Million ≈ $19.30 Million |
AU$-993.71K ≈ $-703.11K |
-0.036x | +65.80% |
| 2002-06-30 | AU$31.14 Million ≈ $22.03 Million |
AU$-3.32 Million ≈ $-2.35 Million |
-0.107x | -81.95% |
| 2001-06-30 | AU$38.07 Million ≈ $26.94 Million |
AU$-2.23 Million ≈ $-1.58 Million |
-0.059x | -39.21% |
| 2000-06-30 | AU$7.58 Million ≈ $5.36 Million |
AU$-318.68K ≈ $-225.49K |
-0.042x | -- |
About Genetic Technologies Ltd
Genetic Technologies Limited, a molecular diagnostics company, engages in the provision of predictive genetic testing and risk assessment tools to help physicians manage people's health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company operates through EasyDNA, AffinityDNA, and GeneType/Corporate segments. It offers BREVAGenplus, a clinicall… Read more